Ads
related to: Moderna
Search results
The Moderna Selloff Gains Steam. An Analyst Has a Few Theories Why.
Barrons.com· 9 hours agoWhat began Tuesday as a puzzling dip in shares of the biotech Moderna accelerated into a larger...
Moderna Stock Is Having Another Very Bad Day. Here’s Why.
Barrons.com· 11 hours agoThe drop comes as Moderna awaits important developments involving its experimental cancer treatment,...
Moderna (MRNA) Stock Outperformed Industry YTD: Here's Why
Zacks via Yahoo Finance· 1 day agoDespite the declining top line, shares of Moderna MRNA continue to soar thanks to its encouraging...
Is Moderna, Inc. (NASDAQ:MRNA) Trading At A 43% Discount?
Simply Wall St. via Yahoo Finance· 4 days agoKey Insights The projected fair value for Moderna is US$294 based on 2 Stage Free Cash Flow to...
Moderna's Options Frenzy: What You Need to Know - Moderna (NASDAQ:MRNA)
Benzinga· 11 hours agoLoading... Loading... Deep-pocketed investors have adopted a bullish approach towards Moderna MRNA , and it's something market players shouldn't ignore. Our tracking of public ...
Moderna Makes Big Play for Big Tech Talent
The Wall Street Journal· 2 days agoCIO Brad Miller has been replacing IT outsourced during the pandemic with a full-time in-house staff as the biotech looks to roll out 15 new products...
Moderna Could Pull Back Even More as Traders Nail Down Profits
TheStreet.com· 1 day agoModerna Could Pull Back Even More as Traders Nail Down Profits
Moderna Shares Had a Bad Day
Barrons.com· 1 day agoThe drop comes as Moderna awaits important developments involving its experimental cancer treatment, a new respiratory vaccine, and a possible avian flu...
Vaccine stocks gain, Moderna and Pfizer in talks with the US on bird flu vaccines By Investing.com
Investing.com· 7 days agoVaccine stocks gain, Moderna and Pfizer in talks with the US on bird flu vaccines
Unveiling Moderna (MRNA)'s Value: Is It Really Priced Right? A C
Guru Focus· 1 day agoModerna Inc (MRNA, Financial) recently experienced a significant daily loss of 7.74%, yet it boasts a 3-month gain of 72.72%. This analysis aims to explore Moderna ...